Insights from Experts at Mayo Clinic on Translating Evidence to Clinical Practice - Episode 2

Frontline Quadruplet Therapy in NDMM: GMMG-HD7

, , ,

Shared insight on the GMMG-HD7 study, which utilized a frontline isatuximab-containing quadruplet regimen in patients with newly diagnosed multiple myeloma.